Literature DB >> 20060808

An evolutionally conserved Lys122 is essential for function in Rhodospirillum rubrum bona fide RuBisCO and Bacillus subtilis RuBisCO-like protein.

Toshihiro Nakano1, Hiroki Ashida, Eiichi Mizohata, Hiroyoshi Matsumura, Akiho Yokota.   

Abstract

Ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO) and RuBisCO-like protein (RLP) catalyze similar enolase-type reactions. Both enzymes have a conserved non-catalytic Lys122 or Arg122 on the beta-strand E lying in the interface between the N- and C-terminal domains. We used site-directed mutagenesis to analyze the function of Lys122 in the form II Rhodospirillum rubrum RuBisCO (RrRuBisCO) and Bacillus subtilis RLP (BsRLP). The K122R mutant of RrRuBisCO had a 40% decrease in k(cat) for carboxylase activity, a 2-fold increase in K(m) for CO2, and a 1.9-fold increase in K(m) for ribulose-1,5-bisphosphate. K122M and K122E mutants of RrRuBisCO were almost inactive. None of the substitutions affected the thermal stability of RrRuBisCO. The K122R mutant of BsRLP had a 32% decrease in k(cat) and lower thermal stability than the wild-type enzyme. The K122M and K122E mutants of BsRLP failed to form a catalytic dimer. Our results suggest that the lysine residue is essential for function in both enzymes, although in each case, its role is likely distinct. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20060808     DOI: 10.1016/j.bbrc.2010.01.017

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Structure-function studies with the unique hexameric form II ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco) from Rhodopseudomonas palustris.

Authors:  Sriram Satagopan; Sum Chan; L Jeanne Perry; F Robert Tabita
Journal:  J Biol Chem       Date:  2014-06-18       Impact factor: 5.157

2.  MtnBD is a multifunctional fusion enzyme in the methionine salvage pathway of Tetrahymena thermophila.

Authors:  Toshihiro Nakano; Izuru Ohki; Akiho Yokota; Hiroki Ashida
Journal:  PLoS One       Date:  2013-07-01       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.